Funded Tech Companies

Variantyx

Variantyx, operating out of Framingham, received equity investments from Robert Bosch Venture Capital, Pitango Venture Capital and 20/20 HealthCare Partners.

Company Overview

Contact Information

Company Background Information

Overview

Variantyx is a CLIA/CAP laboratory providing Genomic Unity, a whole genome sequencing (WGS)-based testing program for diagnosis of rare inherited disorders. Its single method approach to comprehensive genetic testing identifies multiple variant types within a single patient sample to provide a unified clinical report.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/27/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Haim Neerman

        

Chief Operating Officer

Yaron Rachmany

        

Chief Scientific Officer

Noam Shomron

        

Vice President

Daryl Spinner

        

VP - Customer Service

Tomer Jackman

        

VP - Marketing

Jennifer Hogan

        

VP - Sales

Chris Zerwas

        

Company Investors

• Robert Bosch Venture Capital
• Pitango Venture Capital
• 20/20 HealthCare Partners
• New Era Capital Partners (Gideon Argov)
• Peregrine Ventures
• IBM Ventures
• Global Health Sciences Fund
• Pitango Venture Capital (Guy Ezekiel)

Browse more funded tech companies:

Variant Bio | Variation Biotechnologies

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary